Intapp vs Veeva

10-K Financial Filing Analysis for Intapp (2026-08-14)

Intapp, Inc. reported its financial results for the fiscal year ended June 30, 2026, delivering total revenue of $577.8 million with a strong gross margin of 76% and operating cash flow of $146.8 million. Total Annual Recurring Revenue (ARR) grew 22% year-over-year to $590.5 million, propelled by a 29% expansion in Cloud ARR to $495.7 million, which now comprises 84% of total ARR. The company maintained strong net retention, demonstrating a trailing twelve months Cloud Net Revenue Retention (NRR) rate of 123%. Operational expansion was supported by the roll-out of Intapp Celeste, its agentic AI coworker designed for vertical workflows across legal, accounting, and private capital firms. Remaining performance obligations reached $833.0 million, and enterprise clients generating over $50,000 ARR rose 10% to more than 1,400. During the fiscal year, Intapp returned capital to shareholders via $275.2 million in common share repurchases, maintaining $162.8 million in cash and cash equivalents.

• Total revenue reached $577.8 million for FY2026 with a gross margin of 76% and operating cash flow of $146.8 million.
• Cloud ARR grew 29% YoY to $495.7 million, representing 84% of total ARR ($590.5 million), with a Cloud NRR of 123%.
• Enterprise clients with >$50k ARR increased 10% to over 1,400, while RPO expanded to $833.0 million.

Intapp News Room: New Blog Posts on AI Governance, Firm AI, and Compliance

Intapp published several new blog posts in late September 2026, including 'On-premises Walls was built for a world before AI', 'Firm AI and the future of Big Law', 'Stop buying AI features. Build the foundation.', and 'How EMEA law firms are moving to Intapp Compliance with Celeste'.

Intapp Blog: New Posts on EMEA Compliance, AI Cost, and ILTACON Takeaways

Intapp published new blog posts on September 24, 2026, covering EMEA law firm adoption of Intapp Compliance with Celeste, the real cost of building AI infrastructure, and key takeaways from ILTACON 2026 on AI and information governance.

IQVIA Expands Veeva Partnership with Clinical Operations Applications

IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.

• IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
• Partnership expansion extends the previously announced EDC partnership.
• All Veeva clinical solutions will be available through IQVIA for sponsors.

Servier Adopts Veeva OpenData Globally for AI

Servier, a French pharmaceutical company, is standardizing its customer reference data across more than 80 countries with Veeva OpenData, part of Veeva Data Cloud. This initiative builds on Servier's use of Veeva Link Key People and aims to create an AI-ready data foundation by harmonizing fragmented data silos. The centralized data will help commercial and medical teams gain faster insights and improve efficiency. Liam Hanrahan, Director of Global Operations Excellence at Servier, highlighted that the centralized data will improve processes and enable a semantic layer for better engagement with key healthcare professionals. Veeva's president, Kilian Weiss, emphasized that 89% of AI initiatives fail due to data challenges, and Servier's data-first approach demonstrates industry leadership. The adoption replaces fragmented silos and ensures consistency for scaling advanced analytics and AI.

• Servier standardizes customer reference data with Veeva OpenData across more than 80 countries.
• The initiative builds on Servier's use of Veeva Link Key People.
• Veeva OpenData is part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass.

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.